Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
STRUNCK, ET AL v. QUESTCOR PHARMACEUTICALS, INC.
Case Number:
2:12-cv-00175
Court:
Nature of Suit:
Other Statutes: False Claims Act
Judge:
Firms
Companies
Sectors & Industries:
-
March 07, 2022
Mallinckrodt Inks $260M Deal Ending DOJ Medicaid Claims
Mallinckrodt ARD LLC has agreed to pay $260 million to resolve government allegations that it underpaid Medicaid rebates for its Acthar gel products and paid illegal kickbacks to induce Medicare patients to buy its drugs, the U.S. Department of Justice said Monday.
-
May 27, 2021
Judge Questions Bid To Move Acthar Cases To Delaware
A member of the Judicial Panel on Multidistrict Litigation on Thursday questioned Mallinckrodt ARD LLC's push to have a battery of antitrust cases over sales of the anti-seizure drug Acthar transferred to federal court in Delaware where the company is currently making its way through bankruptcy proceedings.
-
September 05, 2019
Mallinckrodt Pays $15M In 'Wine And Dine' FCA Case
The U.S. Department of Justice has finalized an agreement in Pennsylvania federal court with Mallinckrodt Pharmaceuticals to pay $15.4 million to end a federal probe into alleged "wine and dine" tactics used to market a drug to doctors, the DOJ said Wednesday.
-
June 05, 2019
Mallinckrodt Used Charity As Kickback Conduit, Feds Say
The federal government claimed Wednesday that Mallinckrodt used a charitable foundation to pay kickbacks to improperly boost the prices of its anti-seizure drug H.P. Acthar Gel, joining a pair of whistleblower suits that similarly claim the company paid doctors to promote the drug.